Author(s): Angulo S, Morales A, Danese S, Llacuna L, Masamunt MC
Abstract Share this page
Probiotics appear to be beneficial in inflammatory bowel disease, but their mechanism of action is incompletely understood. We investigated whether probiotic-derived sphingomyelinase mediates this beneficial effect.
This article was published in PLoS One
and referenced in Immunotherapy: Open Access